Cartilage is synthesized and maintained by chondrocytes, and is composed primarily of water, proteoglycan and collagen. The degradation of cartilage in vitro and in vivo is mediated by neutral endopeptidases from the metalloproteinase class of enzymes, which includes matrix metalloproteinases (MMPs) and ARAMs (a disintegrin and metalloproteinase protein family) 0)• The role of MMP-3 in rheumatoid arthritis (RA) has been highlighted from both pathophysiological studies and clinical studies 11). Moreover, tissue inhibitors of metalloproteinases (TIMPs) tightly control the activities of the MMPs in a 1: 1 ratio 12)
Metalloproteinases play a crucial role in tissue remodeling, as well as in the destruction of cartilage and bone in an arthritic joint, due to their ability to degrade a wide variety of extracellular matrix components 13). Their substrates include aggrecan, laminin, elastin and the collagens. MMPs also play a role in angiogenesis and inflammation 12,14) Membrane Type-1 (MT1) -MMP is anchored to the cell surface via a transmembrane domain and also has a cytoplasmic tail. Its substrates include collagen, fibronectin, laminin, vbronectin and proteoglycan 14). The production and release of MMPs is dependent on the cellular microenvironment, and is induced by several factors including the proinflammatory cytokine interleukin-i /3 (IL-i$) 15) Metalloproteinases are inhibited by TIMPs, including TIMP-1, which also inhibits angiogenesis, and TIMP-3, which also inhibits some ADAMs, especially ADAM-1714). Members of the ADAM family have a disintegrin domain that can bind to integrins and prevent cell-cell interactions. They also possess a cysteine-rich, epidermal growth factor-like transmembrane domain and a cytoplasmic tail domain. The roles of ADAM-15 and ADAM-17 in cartilage have been described, and ADAM-17 is also known for its ability to release tumor necrosis factor (TNF) -a from the cell surface 12). The 67 kDa laminin receptor (67LR) is a high affinity non-integrin laminin receptor 16), and appears in cancer cells with high malignancy. The interaction of cancer cells with laminin has been implicated in tumor metastasis and invasiveness, and 67LR is believed to be involved in this process. It was recently reported that 67LR might be the receptor for EGC G 17)
Unlike green tea polyphenols, few studies have reported the effects of black tea polyphenols, such as TF3, in chondrocytes.
In the present study, the ability of TF3 and EGCG to affect mRNA expression of MMPs, ADAMS, TIMPs and 67LR in IL-1$-induced mouse chondrocytes was investigated.
Materials and Methods

Reagents
Mouse recombinant IL-1/3, EGCG and TF3 was obtained from Wako Pure Chemical Industries Ltd (Osaka).
Isolation o f Primary Chondrocytes
Primary chondrocytes were isolated from neonatal ddy mice (less than postnatal day 7). Preparation o f total RNA After 1 week, TF3 (100 jiM) or EGCG (100 jiM) was added to the cultured mouse chondrocytes, with or without IL-13 (10 jig l L), for 20 hours before mRNA extraction. The cultured chondrocytes were assigned to five groups as follows : control (medium alone, n =19) ; 10 jig l L IL-1/3 (n =18) ; 10 jig I L IL-1/ + 100 jiM EGCG (n = 9) ; 10 jig I L IL-1/3 + 100 jiM TF3 (n =18) ; 100 ,uM EGCG (n = 5) or 100 ,uM TF3 (n =13) . After cells were collected, total RNA was isolated using an RNeasy Mini kit (Qiagen K.K., Tokyo) and quantified by measuring the optical density at 260 nm. Each RNA sample was diluted with RNase-free water and levels of mRNA normalized. Total RNA was reverse transcribed using an ExScriptTM RT reagent kit (Takara Bio Inc., Shiaa) 19, 20) Quantitative Real-Time PCR
The real-time polymerase chain reaction was used to quantify mRNA levels of MMP-3, MMP-9, MMP-13, MT1-MMP, ADAM-15, ADAM-17, TIMP-1, TIMP-3 and 67LR in the mouse chondrocytes.
Primers were purchased from Takara. Amplification of the corresponding cDNAs was performed on a LightCycler (Roche Diagnostics K.K., Tokyo) using SYBR'R)Premix Ex TagTN1 (Perfect Real Time, Takara) 192o) Fluorescence data were analyzed using the LightCycler software (Roche). Table 1 shows the Takara ID number and the polymerase chain reaction program. Each primer pair generated a single product of the appropriate size when visualized by 2 % agarose gel electrophoresis. The melting curve pattern confirmed a single melting peak. The mRNA levels were compared to the standard (18s rRNA) 21), and relative expression ratios were subsequently calculated. 
Results
Examination of the polygonal cobblestone morphology of mouse chondrocytes by light microscopy showed that chondrocytes of rounded morphology were slightly increased in size by IL-1/3 (Fig. 1B) . However, the addition of TF3 appeared to prevent this change (Fig .  1C) , with TF3 alone not affecting the morphology of the chondrocytes (Fig. 1D) .
The expression of MMP mRNA, especially MMP-3, MMP-9 and MMP-13, was significantly increased by IL-1/3 ( Fig. 2A, 2B, 2C) , and TF3 suppressed this IL-1$-induced increase and 36% by TF3 and EGCG, respectively (Fig. 2B ). MMP-13 mRNA expression was also increased 7.8-fold by interleukin-1 a, and TF3 and EGCG reduced this increase by 39% and 32%, respectively (Fig. 2C) . Levels of MMP mRNA expression were generally not changed by TF3 or EGCG alone ( Fig. 2A, 2B, 2C ).
The expression of MTI-MMP mRNA was not changed by IL-1,3 or EGCG, but was slightly increased by TF3 (Fig. 2D) . None of the treatments affected ADAM-15 mRNA expression (Fig. 3A) , although the level of ADAM-17 mRNA in the chondrocytes was increased by TF3 and by the combination of IL-1/3 and TF3 (Fig. 3B) . The addition of IL-1,3 to cultured chondrocytes tended to increased TIMP-1 mRNA levels, but the level of TIMP-1 mRNA did not change significantly in the treatment groups (Fig. 4A) . In contrast, IL-1/3 significantly decreased TIMP-3 mRNA expression by 14%, and TF3 or EGCG reversed this decrease by 93% or 56%, respectively. Interestingly, addition of either TF3 or EGCG to cultured chondrocytes increased TIMP-3 mRNA expression (Fig. 4B) . The level of 67LR mRNA did not change in the treatment groups (Fig. 5) kinase and activator protein-1 (AP-1) pathways in human chondrocytes25), and TF3 and EGCG also inhibit AP-1 and nuclear factor-KB (NF-KB) activation27). MMP-3, MMP-9 and MMP-13 have promoter sites for AP-1 and NF-KB and l or are influenced by these transcription factors 14) . Thus, it is possible that TF3 and EGCG inhibit MMP mRNA expression via these transcription factors. However, TF3 and EGCG do not inhibit the signal transduction pathways equally. For example, EGCG disrupts the association of MEK1 [MAPK (mitogen-activated protein kinase) / ERK (extracellular signal-regulated kinase) kinase] with Raf-1, possibly by binding to the proline-rich sequences on MEK1, whereas TF3 promotes lysosome-mediated degradation of the Raf-1 protein 8). These mechanisms lead to decreased phospho-MEK1 and phospho-ERK1 / 2 levels within the cell, which then inhibits AP-128). This may explain the differential effect of TF3 and EGCG on MMP mRNA expression observed in the present study. The promoter of ADAM-15 does not contain the TATA or CAAT sequences29). The promoter of ADAM-17 also does not contain the TATA sequence but has both the AP2 (activator protein 2) and SP1 (specificity protein 1) binding sites301). Therefore, unlike the MMPs, the level of ADAM-15 and ADAM-17 mRNA did not change significantly following IL-1ƒÀ treatment of the chondrocytes. Interestingly, TF3 induced ADAM-17 mRNA expression which could, therefore, contribute to joint degradation. However, this is unlikely since the enzymatic balance of the MMPs, ARAMs and TIMPs is tightly maintained in vivo 32).
A B Fig. 4 . expression of MT1-MMP and ADAM-17 to a similar or greater degree, but these changes were much less when compared to the changes in MMPs. Moreover, TF3 induced mRNA expression of TIMP-3, a natural inhibitor of MMPs and ADAM-1Z TIMP-3 might inhibit the release of TNF-a from cell membrane, which, in turn, inhibits ADAM-17 mRNA production37). The results suggest that TF3 may have a stronger effect on controlling degradation in the inflamed joint cartilage than EGCG, implying that TF3 may be a potent antiinflammatory compound with therapeutic potential. 
